✦ LIBER ✦

Therapy of acute lymphocytic leukemia in childhood with intermediate dose methotrexate and CNS irradiation

✍ Scribed by Haas, R. J. ;Janka, G. ;Gaedicke, G. ;Kohne, E. ;Netzel, B.

Book ID: 104721093
Publisher: Springer-Verlag
Year: 1983
Weight: 581 KB
Volume: 47
Category: Article
ISSN: 1432-0584
DOI: 10.1007/bf00320346

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Intermediate-dose methotrexate versus cr

Intermediate-dose methotrexate versus cranial irradiation in childhood acute lymphoblastic leukemia: A ten-year follow-up

✍ Freeman, Arnold I.; Boyett, James M.; Glicksman, Arvin S.; Brecher, Martin L.; L 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 146 KB 👁 2 views

The cure rate of childhood acute lymphoblas-retrieval rate is 49 Ϯ 10%. For all patients, the tic leukemia (ALL) has improved dramatically. 12-year event-free survival was 37 Ϯ 3.6% and Still there is a paucity of long-term data. With the overall survival was 49 Ϯ 3.5%. There were the improving cur

Oral mucositis and salivary methotrexate

Oral mucositis and salivary methotrexate concentration in intermediate-dose methotrexate therapy for children with acute lymphoblastic leukemia

✍ Ishii, Eiichi ;Yamada, Shin-Ichi ;Higuchi, Shun ;Honjo, Tetsu ;Igarashi, Hisaji 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 335 KB

The relationship between salivary methotrexate (MTX) concentration and severity of oral mucositis after administration of MTX was investigated in six children with acute lymphoblastic leukemia. They received two administrations of MTX at 500 mgm' with one third given bolusly and the remainder by 24-

Intermediate-dose methotrexate in the tr

Intermediate-dose methotrexate in the treatment of childhood acute lymphocytic leukaemia: lack of benefit during maintenance therapy following intensive induction therapy

✍ G. E. Janka-Schaub; K. Winkler; H. Jürgens; U. Goebel; P. Gutjahr; H. J. Spaar 📂 Article 📅 1986 🏛 Springer 🌐 English ⚖ 454 KB

One hundred and fifty-one children with acute lymphocytic leukaemia (ALL) received multiple agent induction chemotherapy followed by intensive phase treatment. One hundred and thirty-seven patients were randomised for the first year of maintenance treatment to receive reinforcement therapy (pulses)

Intermediate dose methotrexate in childh

Intermediate dose methotrexate in childhood acute lymphoblastic leukemia resulting in decreased incidence of testicular relapse

✍ Martin L. Brecher; Vivian Weinberg; James M. Boyett; Lucius F. Sinks; Barbara Jo 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 433 KB 👁 2 views

Six hundred thirty-four children with acute lymphoblastic leukemia (ALL) were randomized to receive sanctuary therapy consisting of either cranial irradiation (CRT) plus intrathecal (IT) methotrexate (MTX) or three courses of intermediate-dose methotrexate (IDM) plus intrathecal methotrexate. Two hu

Meningosis prophylaxis with intrathecal

Meningosis prophylaxis with intrathecal 198Au-colloid and methotrexate in childhood acute lymphocytic leukemia

✍ O. Metz; W. Stoll; W. Plenert 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 English ⚖ 488 KB

Since 1972, telecobalt irradiation plus intrathecal methotrexate (ITMTX) has been successfully replaced in Jena by intrathecal colloidal radioactive gold (198Au) plus ITMTX for meningosis prophylaxis in leukemia. Seventy-three children with acute lymphocytic leukemia (ALL) were given 1.24-4.89 mCi (

Treatment of childhood acute lymphoblast

Treatment of childhood acute lymphoblastic leukemia with intermediate-dose cytosine arabinoside and adriamycin

✍ Ishii, Eiichi ;Hara, Toshiro ;Ohkubo, Kenshi ;Matsuzaki, Akinobu ;Takeuchi, Taka 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 389 KB